Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSYH8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,650
Award facts
- Contract value 100% obligated
- $25,650.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $25,650.18 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injections, a biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions. The contract was awarded on January 21, 2026, with a completion date of January 22, 2026, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a ceiling value of $999,999,999 through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor supplying critical medical products to military healthcare systems and other federal agencies through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. As a prime vendor under DLA's pharmaceutical support program, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FSYH8?
SPE2DR26FSYH8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FSYH8 worth?
The government has obligated $25,650 on SPE2DR26FSYH8.
Is contract SPE2DR26FSYH8 an order under another contract?
Yes. SPE2DR26FSYH8 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSYH8 competed?
The extent of competition for SPE2DR26FSYH8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award